Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
May 13, 2020
QurAlis officially launches under a $42 million series A round with a focus on new therapies for amyotrophic lateral sclerosis (ALS) and genetically related frontotemporal dementia (FTD).
May 13, 2020
QurAlis raises a $42,000,000 series A round.
November 19, 2018
QurAlis raises a $5,500,000 seed round from BioInnovation Capital.
November 2018
QurAlis raises a $5,500,000 seed round from Amgen Ventures, BioInnovation Capital and MP Healthcare Venture Management.
Funding Rounds
SBIR/STTR Awards
Patents
Further Resources
Title
Author
Link
Type
Date
QurAlis Raises $5.5 Million Seed Round
BusinessWire
Web
News
Title
Author
Date
Publisher
Description
Viva Biotech Holdings
March 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- March 2nd-6th, 2021, Viva Biotech successfully hosted the 2021 Partnership Summit. Over 300 attendees joined the Summit, including...
Ben Adams
July 1, 2020
FierceBiotech
In May, startup QurAlis got a $42 million series A toward targeting the genetic causes of two rare diseases: amyotrophic lateral sclerosis and genetically related frontotemporal dementia.
Ben Adams
May 13, 2020
FierceBiotech
QurAlis has officially launched under a $42 million series A round with a focus on new therapies for amyotrophic lateral sclerosis and genetically related frontotemporal dementia.
References
4
Type: Web page
https://quralis.com/about-us/leadership/kasper-roet-phd/
Organization
CompanyCompany attributes
Biotechnology
Stem cell
Biomedical engineering
Biopharmaceutical
EngineeringLocation
Cambridge, MassachusettsCompany Operating Status
Active
CEO
Full Address
100 Cambridge Park Drive, 5th Floor, Cambridge, MA 02140, US
BioInnovation Capital
MP Healthcare Venture Management
Amgen Ventures
Viva BiotechDUNS Number
080705732
Founded Date
2016
Email Address
info@quralis.com
Phone Number
+17818167031
Total Funding Amount (USD)
53,000,000
Latest Funding Round Date
May 13, 2020
Latest Funding Type
Series A roundOther attributes
Country
United StatesCategories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Henry Ogolla
Passionate about reading and writing. - 3
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 4
Katrina-Kay Pettitt
Data Duchess @ Golden - 5
Kirill Pichugin
Writer - 6
Kombain Mashina
why - 7
Erin Scherfner
loading information... - 8
Duzenko Andrey
Extensive experience in development and interaction with the community - 9
Ольга Дрокина
chef
